GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Medplus Health Services Ltd

Medplus subsidiary faces 2-day license suspension, Rs 0.71 lacs revenue loss

REGULATORY ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 05 Aug 2026, 06:38 PM IST  ·  BSE ID: 947ffdb4-9fe5-4082-9514-a34d8b2a663d
View Original BSE Filing (PDF)
💡
In Simple Terms
One of Medplus's pharmacies in Karnataka had its operating license suspended for two days.
🤖 AI Summary
  • Optival Health Solutions, a Medplus subsidiary, faces a two-day drug license suspension for a Karnataka store.
  • The suspension is due to alleged violations of the Drugs and Cosmetics Act, 1940 and Rules, 1945.
  • The affected store is located at Jain Mandir Raichur, Karnataka.
  • A potential revenue loss of Rs 0.71 lacs is estimated from this two-day suspension.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Potential Revenue Loss
Rs 0.71 lacs
Suspension Duration
two days
🏢 How This Affects the Company
📈
Business Impact
The suspension impacts the operations of a single store for a short duration, with minimal disruption to the overall business.
💰
Financial Impact
The direct financial impact is limited to the estimated revenue loss of Rs 0.71 lacs from the two-day store closure.
⚙️
Operational Impact
Operations at the specific Raichur store are paused for two days. Other operations remain unaffected.
⚠️
Risk Impact
This indicates ongoing regulatory scrutiny on subsidiary store licenses in certain regions, a recurring concern.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders. This is an operational update.
👤
Who Is Affected
All shareholders are informed of operational matters affecting subsidiaries. The direct financial impact is minimal on consolidated results.
🔍
Management Signal
This update highlights management's commitment to disclosing regulatory actions impacting its subsidiaries promptly as required.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future disclosures on similar license suspensions for subsidiary stores.
Company's proactive measures to address recurring compliance issues.
Quarterly results for impact on consolidated revenue.
MEDIUM RISK Recurring license suspensions for subsidiary stores indicate potential operational and compliance challenges.
💡 Investor Takeaway
Medplus subsidiary Optival Health Solutions' store in Raichur, Karnataka, received a two-day drug license suspension, leading to an estimated Rs 0.71 lacs revenue loss.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Subsidiary store drug license suspended for two days in Karnataka, impacting operations.
  • Potential revenue loss of Rs 0.71 lacs flagged due to regulatory non-compliance.
📅 Company Track Record
Medplus subsidiaries have faced multiple license suspensions in recent months, including a 5-day suspension in late July 2026, two 2-day suspensions in late July 2026, and a 10-day suspension in mid-June 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What happened to Medplus Health Services Ltd.'s subsidiary in Karnataka?
Optival Health Solutions Private Limited, a subsidiary of Medplus, received a two-day suspension order for its drug license for a store in Raichur, Karnataka.
What is the estimated financial impact of this suspension on Medplus?
The company estimates a potential revenue loss of Rs 0.71 lacs due to the two-day suspension of the store's operations.
Why was the drug license of the Medplus subsidiary store suspended?
The suspension is due to alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
When did Medplus receive the suspension order?
Medplus received the order on August 04, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.